Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / / edited by Mukesh Nandave
| Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / / edited by Mukesh Nandave |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (609 pages) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Pharmacovigilance Medicine - Research Biology - Research Clinical biochemistry Therapeutics Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry |
| ISBN | 981-9773-80-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_ Introduction of the renin-angiotensin-aldosterone system (RAAS) -- Chapter 2_ Role of anti-hypertensive agents in cardiovascular disorders -- Chapter 3_ (ACE) Angiotensin-converting enzyme inhibitors: Preferred RAAS inhibitor in high-risk patients as compared to angiotensin receptor blockers (ARBs) -- Chapter 4_ Role of (ACE) angiotensin-converting enzyme inhibitors in transforming renin–angiotensin system -- Chapter 5_ The effect of (ACE) Angiotensin-converting enzyme inhibitors vs angiotensin receptor blockers on insulin resistance in hypertensive patients -- Chapter 6_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure -- Chapter 7_ Immunomodulator activity of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients -- Chapter 8_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peripheral artery disease -- Chapter 9_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in covid-19 patients -- Chapter 10_ Recent trends in the management of hypertension through RAAS inhibition. |
| Record Nr. | UNINA-9910899893503321 |
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 1 : Uncovering Diversity and Ethnopharmacological Aspects / / edited by Mukesh Nandave, Rohit Joshi, Jyoti Upadhyay
| Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 1 : Uncovering Diversity and Ethnopharmacological Aspects / / edited by Mukesh Nandave, Rohit Joshi, Jyoti Upadhyay |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (487 pages) |
| Disciplina | 610.72 |
| Altri autori (Persone) |
JoshiRohit
UpadhyayJyoti |
| Soggetto topico |
Medicine - Research
Biology - Research Pharmacology Plant biotechnology Molecular biology Biomedical Research Plant Biotechnology Molecular Biology |
| ISBN | 981-9723-67-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Factors affecting biodiversity and conservation of Medicinal plants -- Chapter 2. Assessment of the Medicinal Flora for Treating Skin Disorders in Indonesia -- Chapter 3. Endophytic Fungal Diversity of Medicinal Plants and Their Role During Stress Response -- Chapter 4. Traditional Knowledge Databases of Medicinal Plants -- Chapter 5. Ethnopharmacognosy of Medicinal Plants: Challenges and Biotechnological Advancements -- Chapter 6. Ethnobotanical and Conservational Studies of Medicinal Plants: A Case Study of Dolichandrone falcata (Wall. Ex DC.) Seem. in Western Ghats, India -- Chapter 7. Bridging Cultures and Medicine: Quantitative Insights in Ethanopahrmacology -- Chapter 8. Unveiling Plant Based Healing Wisdom Through Ethnobotany and Medicinal Ethanopharmacology -- Chapter 9. A Current Perspective of Ethnopharmacology in India -- Chapter 10. Global Regulatory Frameworks and Databases of Medicinal Plants -- Chapter 11. Role of Genome-Based Barcoding in Quality Control and Standardization of Medicinal Plants -- Chapter 12. Future Directions and Emerging Trends in Medicinal Plant DNA Barcoding -- Chapter 13. Conservation of High-Value Medicinal Plants Through Agronomical Approaches -- Chapter 14. Understanding the Interplay: Medicinal Plants and Biotic Stress -- Chapter 15. Metabolomics In Medicinal Plants: Unravelling the Therapeutic Potential of Natural Compounds -- Chapter 16. Exploring the Therapeutic Potential of Secondary Metabolites in Medicinal Plants -- Chapter 17. Integrative Approaches for Enhanced Secondary Metabolite Production -- Chapter 18. Nutraceuticals Derived From Medicinal Plants: A Paediatric Perspective -- Chapter 19. Nutraceutical Formulations From Medicinal Plants: Past, Present and Future -- Chapter 20. Nanobiotechnology for Medicinal Plants: A Comprehensive Review -- Chapter 21. Genetic Enhancement Strategies for Medicinal Plants: Exploring Mutagenesis -- Chapter 22. Evolution and Future Trends in Intellectual Property Rights Related to Medicinal PlantsChapter 1_Biodiversity of Medicinal Plants -- Chapter 2_Endophytic fungal diversity of medicinal plants -- Chapter 3_Medicinal plants and their ethnopharmacological properties -- Chapter 4_Current perspective of ethnopharmacology in India -- Chapter 5_Ethnobotanical studies on medicinal plants -- Chapter 6_Medical ethnopharmacology and ethnobotany -- Chapter 7_Neutraceutical formulations from medicinal plants -- Chapter 8_Quantitative and comparative approaches in ethnopharmacology -- Chapter 9_Ethnopharmacognosy of medicinal plants -- Chapter 10_Traditional knowledge database of medicinal plants -- Chapter 11_Genome based on barcoding of medicinal plants. -Chapter 12_Medicinal plants and nanotechnology -- Chapter 13_Mutagenesis in medicinal plants -- Chapter 14_Advances in micropropagation of medicinal plants -- Chapter 15_Agronomical approaches for conservation of medicinal plants -- Chapter 16_Genome sequencing of medicinal plants -- Chapter 17_Intellectual property rightsrelated to medicinal plants -- Chapter 18_Biotic stress in Medicinal plants -- Chapter 19_Biotic stress in Medicinal plants -- Chapter 20_Medicinal rice of India. |
| Record Nr. | UNINA-9910896530103321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 2 : Revealing the Secrets of Medicinal Plants / / edited by Mukesh Nandave, Rohit Joshi, Jyoti Upadhyay
| Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 2 : Revealing the Secrets of Medicinal Plants / / edited by Mukesh Nandave, Rohit Joshi, Jyoti Upadhyay |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (545 pages) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
JoshiRohit
UpadhyayJyoti |
| Soggetto topico |
Medicine - Research
Biology - Research Pharmacovigilance Pharmacology Plant biotechnology Botany Biomedical Research Drug Safety and Pharmacovigilance Plant Biotechnology Plant Science |
| ISBN | 981-9742-92-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Medicinal potential of traditional rice of India for widespread health benefits -- Chapter 2: Diversity, distribution and genetic resources in Glycyrrhiza glabra Linn. (Mulethi) -- Chapter 3: Genetic resources and breeding strategies for lavender (Lavandula angustifolia Mill) -- Chapter 4: Genetic resources and variations in Picrorhiza kurroa Royle ex Bentham -- Chapter 5: Saussurea costus (Falc) Lipsch: Botanical, biochemical, therapeutical aspects and conservation strategies -- Chapter 6: Distribution, challenges and conservation of an industrially important medicinal plant, pushkarmool -- Chapter 7 - Beyond the Bark: Endophytic Fungal Diversity in Taxus and their Crucial Role in Medicinally Relevant Secondary Metabolites -- Chapter 8- Delving into Medicinal Plant Microbiomes: Utilizing Advanced Approaches to Decipher Functional Potential for Plant Health and Therapeutic Properties -- Chapter 9 - DNA Barcoding of Medicinal Plants for Conservation Purposes -- Chapter 10: Medicinal plant-based nanoparticle synthesis and their diverse applications -- Chapter 11: Exploring the Influence of Nanotechnology on Medicinal Plants: Leveraging Nano-Scale Marvels for Targeted Drug Delivery and Enhanced Therapeutic Efficacy -- Chapter 12- Insight into techniques and applications of metabolomics: a versatile tool for plant research -- Chapter 13: Functional genomics of medicinal plants: A new era towards understanding secondary metabolism -- Chapter 14: Transcriptome analysis unravelling the molecular secrets of medicinal plants -- Chapter 15: Advancements in Medicinal Plants Genome Sequencing to Revolutionize Genomics -- Chapter 16: Big data analysis of medicinal plants: Revolutionizing data mining for applied prospects -- Chapter 17: Phyto-Epigenetics: An approach to unlock myriads of genetic predisposition -- Chapter 18: Challenges, advancement and opportunities in genome editing: A Medicinal plant perspective -- Chapter 19: Intellectual Property Rights Related to Medicinal Plants: Deciphering traditional knowledge landscape -- Chapter 20: Effect and Response of Medicinal Plants to Abiotic Stress: An overview of adaptation strategies -- Chapter 21: Medicinal plants and their clinical uses: From old traditions to targeted drug designing -- Chapter 22: Insights on the Integration of Ethnopharmacology and Omics in Medicinal Plant Research -- Chapter 23: Investigating the Therapeutic Potential of Medicinal Plants in Managing Mental Health Disorders. |
| Record Nr. | UNINA-9910897978903321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Gut Health and Metabolic Syndrome : Optimizations with Microbiome Innovations / / edited by Mukesh Nandave, Ramendra Pati Pandey, Jyoti Upadhyay
| Gut Health and Metabolic Syndrome : Optimizations with Microbiome Innovations / / edited by Mukesh Nandave, Ramendra Pati Pandey, Jyoti Upadhyay |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (466 pages) |
| Disciplina | 616.9041 |
| Altri autori (Persone) |
Pati PandeyRamendra
UpadhyayJyoti |
| Soggetto topico |
Medical microbiology
Molecular biology Clinical medicine - Research Biochemistry Metabolism Metabolism - Disorders Medical Microbiology Molecular Biology Clinical Research Metabolic Disease |
| ISBN | 9789819662463 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Gut Ecology and Metabolic Health: Understanding the Microbiome-Metabolic Syndrome Connection -- Chapter 2. Understanding the Gut Microbiota Blueprint: Insights into its Role in Metabolic Syndrome -- Chapter 3. Linking the Gut Microbiome to Metabolic Syndrome: Exploring the Pathways -- Chapter 4. Dietary Strategies for Metabolic Syndrome: Enhancing Gut Microbiome Health -- Chapter 5. Novel Therapies: Pharmacological Approaches to Modulate the Gut Microbiome in Metabolic Syndrome -- Chapter 6. Integrative Health: Combining Exercise, Lifestyle Changes, and Gut Microbiome for Metabolic Syndrome -- Chapter 7. Mind-Body Interactions: The Role of Psychosocial Factors, Stress, and the Gut Microbiome in Metabolic Syndrome -- Chapter 8. Unveiling the Gut Microbiome's Role in Obesity and Insulin Resistance -- Chapter 9. From Discovery to Application: Clinical Perspectives on Gut Microbiome Research in Metabolic Syndrome -- Chapter 10. Exploring the Ethical, Legal, and Societal Implications of Gut Microbiome Research in Metabolic Syndrome -- Chapter 11. Advances in microbiome sequencing technologies for studying gut health in Metabolic Syndrome. Chapter 12. Microbiome and Metabolic Biomarkers in Metabolic Syndrome -- Chapter 13. Microbiome-Driven Precision Nutrition in Metabolic Syndrome -- Chapter 14. Personalized Microbiome-Based Therapies for the treatment and management of Metabolic Syndrome -- Chapter 15. Future Trends in Gut Microbiome Research in Metabolic Syndrome. |
| Record Nr. | UNINA-9911011648503321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacovigilance Essentials : Advances, Challenges and Global Perspectives / / edited by Mukesh Nandave, Anoop Kumar
| Pharmacovigilance Essentials : Advances, Challenges and Global Perspectives / / edited by Mukesh Nandave, Anoop Kumar |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (478 pages) |
| Disciplina | 363.19463 |
| Altri autori (Persone) | KumarAnoop |
| Collana | Medicine Series |
| Soggetto topico |
Pharmacology
Medicine - Research Biology - Research Pharmacovigilance Medical sciences Pharmacy Public health Biomedical Research Drug Safety and Pharmacovigilance Health Sciences Public Health |
| ISBN | 981-9989-49-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_ Introduction to Pharmacovigilance -- Chapter 2_ History of Pharmacovigilance and Regulatory Actions -- Chapter 3_ Databases Used in Pharmacovigilance Across the Globe -- Chapter 4_ Processing of ADRs -- Chapter 5_ Signal Detection and Aggregate Reporting -- Chapter 6_ Reporting of ADRs across the globe -- Chapter 7_ Pharmacovigilance System in India. - Chapter 8_ Pharmacovigilance System in EU -- Chapter 9_ Pharmacovigilance System in USA -- Chapter 10_ Pharmacovigilance System in non-EU Countries -- Chapter 11_ Vaccine Safety Surveillance -- Chapter 12_ Herbovigilance -- Chapter 13_ Materiovigilance -- Chapter 14_ Hemovigilance -- Chapter 15_ Role of Pharmacogenetics in Pharmacovigilance -- Chapter 16_ Signal Detection and Assessment in Pharmacovigilance -- Chapter 17_ Role of Artificial Intelligence in Pharmacovigilance -- Chapter 18_ Current Challenges and Future Perspectives. |
| Record Nr. | UNINA-9910853988703321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics / / edited by Mukesh Nandave, Priti Jain
| PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics / / edited by Mukesh Nandave, Priti Jain |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (400 pages) |
| Disciplina | 615.19 |
| Altri autori (Persone) | JainPriti |
| Soggetto topico |
Pharmaceutical chemistry
Pharmacology Pharmacovigilance Oncology Drug delivery systems Pharmacy Pharmaceutics Drug Safety and Pharmacovigilance Drug Delivery |
| ISBN | 981-9750-77-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Understanding the Ubiquitin Proteasome System - History and Revolution -- 2. PROTACs: Principles and Mechanisms -- 3. Structural Considerations and Chemistry of PROTAC -- 4. Advantages and Disadvantages of PROTACs -- 5. Novel Technologies in PROTAC Design -- 6. Future of trends in the design and development of PROTAC -- 7. Global Regulatory Requirements Applicable for PROTACs -- 8. Tissue-Specific Targeting Strategies with PROTAC Technology -- 9. Clinical Development OF PROTACs -- 10. Toxicological Aspects of PROTACs -- 11. PROTACs in the management of Prostate Cancer -- 12. Exploring the Role of PROTACs for the Treatment of Breast Cancer -- 13. Role of PROTACs in Hematological Malignancies -- 14. Artificial Intelligence and Machine Learning for Exploring PROTAC in Underutilized Cells -- 15. PROTACs in Treatment of Glioma -- 16. Proteolysis Targeting Chimera (PROTACs) an Attractive Technology in CVD Therapeutics: Opportunities and Challenges -- 17. Delivery systems - miniaturised PROTAC, Nano PROTAC, Aptamer-based RNA PROTAC. |
| Record Nr. | UNINA-9910886089003321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure : Mechanisms and Clinical Applications: A Machine-Generated Literature Overview / / edited by Mukesh Nandave
| Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure : Mechanisms and Clinical Applications: A Machine-Generated Literature Overview / / edited by Mukesh Nandave |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (536 pages) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Medicine - Research Biology - Research Pharmacovigilance Medicine Cardiology Biomedical Research Drug Safety and Pharmacovigilance Clinical Medicine |
| ISBN |
9789819775682
9789819775675 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_ The History of the Development of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors for the Treatment of Diabetes: from biology to Chemistry -- Chapter 2_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors and mechanism of cardiovascular benefits in type 2 diabetes -- Chapter 3_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for primary and secondary protection from cardiovascular and renal diseases in Type 2 diabetes -- Chapter 4_ Sodium-glucose Cotransporter-2 (SGLT2) inhibitors: Emerging opportunities for the treatment of myocardial infarction -- Chapter 5_ Potential Role of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment and Prevention of Diabetic Cardiomyopathy -- Chapter 6_ Contemporary Management, unmet needs, and Therapeutic Potential of Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in congestive heart failure -- Chapter 7 A comprehensive review of preclinical and clinical information on the cardiovascular advantages of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors -- Chapter 8_ Exploring the current selective drugs of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of cardiovascular disease in Type 2 Diabetes -- Chapter 9_ A comprehensive review of Sodium-glucose Cotransporter-2 (SGLT2) inhibitor’s effects on cardiovascular events, mortality, and significant safety outcomes in individuals with type 2 diabetes. |
| Record Nr. | UNINA-9910908379503321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||